Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid for Hemiplegic Shoulder Pain in Subacute Stroke
NCT02465853Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2015
- Primary completion
- Jul 2017
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in hemiplegic shoulder pain (PHS) and rotator cuff injury comparing Hyaluronic Acid with Placebo (2 arms). Primary endpoint: Change from baseline on hemiplegic shoulder sonography at 6 months. Started Jan 2015; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
hemiplegic shoulder pain (PHS)rotator cuff injury
Beyond the preview
Go deeper on NCT02465853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465853.